drug repositioning - anaxomics.comdrug repositioning, also known as drug reprofiling or...
TRANSCRIPT
DRUG REPOSITIONING
Drug repositioning, also known as drug reprofiling or repurposing, is the strategy of discovering new indications for existing drugs or biologics.
Why is drug repositioning useful? Some strong points of drug repositioning compared to de novo development are:
Reduced development costs and time
Longer life cycle and improved return on investment
Possibility of rescuing previously failed and out-of patent compounds
Possibility of extending the patent life of a compound
Increased success rates
What does Anaxomics offer?Drug repositioning can no longer rely on serendipity, but it has to be a directed and rational process. Anaxomics employs its Therapeutic Performance Mapping System (TPMS) proprietary technology to identify new indications for your drugs under the prism of systems biology at any step of the drug development process.
Understanding the full potential of a drug considering a newly characterized target
Identification of new uses for drug combinations of your library
Early exploring of the full range of potential indications for candidates in pre-clinical development
Identification of new uses for commercial drugs
Anaxomics’ cutting-edge expertise in systems biology provides:
Innovative, non-obvious results
Faster approval process
A scientific-based rationale
Medical applicability
Mechanistic hypotheses
New pathways for further research
Biological map around targets
Mathematical model generation
Complete target profile
New indications
1
2
3
4
We o�er a quick and systematic analysis of your pipeline.
Dys
kine
sia
TremorInsomnia
Ata
xia
Parkinsonism
Asthenia
What do you get with this service?Anaxomics provides its clients with comprehensive reports that evaluate the most promising uses for the drug under study.
The delivered document contains a list of potential indications ranked by predictive value as per TPMS calculations. In silico results are manually reviewed by a team of experts who filter and enrich them in accordance with up-to-date scientific knowledge. Report conclusions are adapted to specific research questions.
To whom is this service addressed? We at Anaxomics are glad to offer our services to interested clients and, more specifically, to:
Academic researchers
Clinical researchers
Pharmaceutical companies
Biotechnology companies
Why Anaxomics? The Anaxomics team is composed of highly-qualified experts in clinical research, computational science, biotechnology and systems biology. Anaxomics is a client-focused company, with strong stress on quality and innovative approaches to solve bottlenecks in drug discovery and clinical development.
How can you contract the service? Fee-for-service
Subcontracts through grants
Scientific collaboration through R&D grants/consortiums
Nutraceutical industry
Anaxomics Biotechc/Balmes, 89, 4º 2ª 08008, BarcelonaSpain
Our experience is our best assetWe have offered services to a wide array of leading biotech and pharmaceutical companies. Additionally, we regularly
collaborate with prestigious international research institutions in public-private partnerships. Anaxomics currently
participates in eight research consortiums under the EU 7th Framework Program, and has also been involved in FIS, CDTI,
CANADEKA and other publicly funded research programmes.
Anaxomics has also been finalist for the 2011 Red Herring Top 100 Innovative
European Company Award and 4th place worldwide in IMPROVER challenge 2012
Contact us: We are pleased to answer your questions and queries.
If you want different results, then you have to explore different solutions
Albert Einstein
+34 93 451 67 17
www.anaxomics.com